Oral molecule human trial for treating advance stage tumors with fibroblast starts... Sep 05
RAIN-32 is a potent and selective MDM2 inhibitor that has been evaluated in clinical trials for solid tumors and hematologic malignancies... Sep 03
-Advertisements-